SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : TGEN - Targeted Genetics Corporation
TGEN 8.230+0.9%Nov 7 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: James Reynolds who started this subject6/14/2003 11:34:33 AM
From: tktrimbathRead Replies (1) of 557
 
Financing in perspective

A few months ago if I heard that TGEN managed a few million dollars in financing without incurring massive debt I would have been pleased. More money holds off fiscal collapse. At that time I would have been pleased if the stock simply held its sub $1 value without going to zero.

Now when TGEN gets more than $10 million the stock drops to the low $2s. I don't like dilution but that is easily overcome by the nice chunk of cash TGEN has generated.

This seems that it can only mean the company has a better chance of surviving longer. Whether it is long enough will continue to be the question all the way through marketability of the first drug. But for now I'll take the drop from $4 to $2.20 as very temporary and breathe a sigh of relief that they have more cash to work with.

Or did I miss something?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext